查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1300969

表觀遺傳學診斷市場規模、份額和趨勢分析報告：按產品（試劑、試劑盒、儀器、□、服務）、按應用（腫瘤學、非腫瘤學）、按技術、按地區、細分市場趨勢，2023 ～2030

Epigenetics Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments, Enzymes, Services), By Application (Oncology, Non-oncology), By Technology, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

表觀遺傳學診斷市場增長和趨勢

根據 Grand View Research, Inc. 的最新研究報告，全球表觀遺傳學診斷市場規模在預測期內將以 15.10% 的複合年增長率擴大，預計到 2030 年預計到2020年將達到391.5億美元。

這一增長是由重度抑鬱症 (MDD) 患病率上升推動的。 據世界衛生組織稱，到 2023 年，約 5% 的成年人將患有抑鬱症。 此外，根據 NCBI 2022 年發布的一項研究，全球約有 2.8 億人患有 MDD。 此外，表觀遺傳藥物發現領域的技術進步也促進了增長。 根據 BioMed Central Ltd. 發表的研究，人們越來越關注構建選擇性異構體抑製劑以提供抗腫瘤功效。

此外，公共和私人實體在表觀遺傳學領域的投資增加預計將在 2023-2030 年推動市場發展。 例如，2023 年 3 月，單劑量表觀遺傳編輯系統領域的領導者 Chroma Medicine, Inc. 完成了 1.35 億美元的 B 輪融資。 該資金由谷歌風投牽頭，用於表觀遺傳編輯技術領域的進步。

行業領導者正在採取各種策略來鞏固其市場地位並擴大其客戶群。 例如，2022 年 5 月，Cardio Diagnostics, Inc. 和 Mana Capital Acquisition Corp. 建立了業務聯盟。 該交易的目的是創建一家上市公司，通過表觀遺傳學的應用來改變心血管疾病。 此外，2022 年 2 月，Element Biosciences 和 Dovetail Genomics 宣佈建立合作夥伴關係，以展示 Dovetail 在 Element 的 AVITI 系統上的下一代測序文庫製備服務的性能和價值。

COVID-19 大流行為表觀遺傳學研究人員創造了一個機會來研究 COVID-19 病毒對 DNA 甲基化變化和骨髓分化的影響，從而對市場產生積極影響。 根據NCBI 2022年發表的一項研究，表觀遺傳修飾不僅在維持細胞穩態和基因組方面發揮著重要作用，而且還提供了病毒感染的病因和發病機制的信息。

表觀遺傳學診斷市場報告亮點

  • 從產品來看，試劑領域在 2022 年佔據市場主導地位，份額為 31.50%。 這種增長歸因於表觀遺傳學研究中對試劑的需求不斷增長。
  • 從技術角度來看，隨著慢性病治療需求的不斷增長，DNA甲基化領域將在2022年佔據最大的收入份額，達到46.73%。
  • 按應用劃分，腫瘤學應用領域在 2022 年佔據最大收入份額，達到 69.23%。 該細分市場的增長歸因於癌症發病率的增加，對癌症領域表觀遺傳學研究的需求不斷增加。
  • 由於擁有知名的市場參與者和技術先進的醫療保健基礎設施，北美在 2022 年以 38.18% 的收入份額佔據市場主導地位。 此外，意識的提高加上高研發支出預計將推動預測期內的增長。
  • 主要市場參與者包括 Roche Diagnostics、Thermo Fisher Scientific, Inc. Ltd.、Novartis AG、Element Biosciences, Inc.、Dovetail Genomics LLC.、Illumina, Inc.、ValiRx Plc.、Abcam plc. is。

內容

第一章調查方法及範圍

  • 信息獲取
  • 信息或數據分析
  • 市場範圍和細分定義
  • 市場模式
    • 按公司市場份額進行市場調查
    • 區域分析

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章表觀遺傳學診斷市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
    • 市場機會分析
  • 表觀遺傳學診斷市場分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 的影響分析

第四章產品業務分析

  • 表觀遺傳學診斷市場：產品變異分析
  • 試劑
    • 2018-2030 年試劑市場（百萬美元）
  • 套件
    • 2018-2030 年套件市場（百萬美元）
    • 芯片測序套件
    • 全基因組擴增試劑盒
    • 亞硫酸氫鹽轉換套件
    • RNA測序試劑盒
    • 其他
  • 設備
    • 2018-2030 年設備市場（百萬美元）
  • □
    • □市場，2018-2030 年（百萬美元）
  • 服務
    • 2018-2030 年服務市場（百萬美元）

第五章應用業務分析

  • 表觀遺傳學診斷市場：應用的變異分析
  • 腫瘤學
    • 腫瘤市場，2018-2030 年（百萬美元）
    • 實體瘤
    • 其他
  • 非腫瘤學
    • 非腫瘤市場，2018-2030 年（百萬美元）
    • 炎症性疾病
    • 代謝性疾病
    • 感染
    • 心血管疾病
    • 其他

第 6 章技術業務分析

  • 表觀遺傳學診斷市場：技術波動分析
  • DNA甲基化
    • DNA 甲基化市場，2018-2030 年（百萬美元）
  • 組蛋白甲基化
    • 2018-2030 年組蛋白甲基化市場（百萬美元）
  • 組蛋白乙□化
    • 2018-2030 年組蛋白乙□化市場（百萬美元）
  • 大非編碼RNA
    • 大型非編碼 RNA 市場，2018-2030 年（百萬美元）
  • 微小RNA修飾
    • 2018-2030 年 MicroRNA 修飾市場（百萬美元）
    • 2018-2030 年染色質結構市場（百萬美元）

第七章區域業務分析

  • 2022 年和 2030 年表觀遺傳學診斷市場份額（按地區）
  • 北美
    • SWOT分析
    • 北美表觀遺傳學診斷市場，2018-2030 年（百萬美元）
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 2018-2030 年歐洲表觀遺傳學診斷市場（百萬美元）
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 亞太表觀遺傳學診斷市場，2018-2030 年（百萬美元）
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 泰國
    • 韓國
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲表觀遺傳學診斷市場，2018-2030 年（百萬美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • SWOT分析
    • MEA 表觀遺傳學診斷市場，2018-2030 年（百萬美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 8 章競爭格局

  • 公司分類
  • 戰略規劃
  • 2022 年公司市場份額分析
  • 公司簡介/列表
    • Roche Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Eisai Co. Ltd.
    • Novartis AG
    • Element Biosciences, Inc.
    • Dovetail Genomics LLC.
    • Illumina, Inc.
    • ValiRx Plc.
    • Abcam plc.
Product Code: GVR-2-68038-831-2

Epigenetics Diagnostics Market Growth & Trends

The global epigenetics diagnostic market size is expected to reach USD 39.15 billion by 2030, expanding at a CAGR of 15.10% over the forecast period, according to a new study by Grand View Research, Inc. The growth is attributed to the rising incidence of major depressive disorder (MDD). According to WHO, in 2023, around 5% of adults suffer from depressive disorder. Furthermore, according to a study published by NCBI in 2022, around 280 million people are affected by MDD across the globe. Additionally, technological advancement in the field of epigenetic drug discovery is also contributing to the growth. A study published by BioMed Central Ltd. states that there is an increasing inclination towards selective isoform inhibitor construction to produce anti-tumor effects.

Moreover, increasing investment from public and private organizations in the field of epigenetics is anticipated to drive the market during 2023-2030. For instance, in March 2023, Chroma Medicine, Inc., a leader in single-dose epigenetic editing systems, completed a USD 135 million Series B funding. The financing was led by Google Ventures for the advancement in the field of epigenetic editing technology.

Key players in the industry are adopting various strategies to strengthen their market position and expand their customer base. For instance, in May 2022, Cardio Diagnostics, Inc., and Mana Capital Acquisition Corp. entered a business agreement. The goal of this agreement was to create a publicly listed company to transform cardiovascular disease through the application of epigenetics. Moreover, in February 2022, Element Bioscience, Inc., and Dovetail Genomics announced a partnership to demonstrate the performance and value of Dovetail's next-generation sequencing library prep service on Element's AVITI system.

The COVID-19 pandemic has positively impacted the market by creating opportunities for epigenetics researchers to study the impact of the COVID-19 virus on DNA methylation changes and myeloid differentiation. A study published by NCBI in 2022 states that epigenetic modification not only plays a crucial role in the maintenance of cellular homeostasis and the genome but also provides information about the cause and development of virus infection.

Epigenetics Diagnostics Market Report Highlights

  • Based on product, the reagent segment dominated the market with a share of 31.50% in 2022. The growth is attributed to the rising demand for reagents in epigenetic research studies.
  • Based on technology, the DNA methylation segment accounted for the largest revenue share of 46.73% in 2022, owing to its increasing demand in chronic disease treatment.
  • Based on application, the oncology application segment accounted for the largest revenue share of 69.23% in 2022. The segment growth is attributed to the increasing demand for epigenetics research in the field of cancer owing to its growing incidences.
  • North America dominated the market with a revenue share of 38.18% in 2022, owing to the presence of prominent market players and technologically advanced healthcare infrastructure. Moreover, rising awareness coupled with high R&D expenditure is anticipated to drive growth over the forecast period.
  • Some of the major players in the market are Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., Novartis AG, Element Biosciences, Inc., Dovetail Genomics LLC., Illumina, Inc., ValiRx Plc., and Abcam plc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Epigenetics Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Rise in number of geriatric patients
      • 3.2.1.3. Expanding governmental initiatives in the epigenetics field
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Worries about diagnoses using epigenetics in terms of standardization
      • 3.2.2.2. Lack of skilled professionals
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Improvement in healthcare infrastructure in developing economies
  • 3.3. Epigenetics Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Epigenetics Diagnostics Market: Product Movement Analysis
  • 4.2. Reagents
    • 4.2.1. Reagents Market, 2018 - 2030 (USD Million)
  • 4.3. Kits
    • 4.3.1. Kits Market, 2018 - 2030 (USD Million)
    • 4.3.2. Chip Sequencing Kit
      • 4.3.2.1. Chip sequencing kit Market, 2018 - 2030 (USD Million)
    • 4.3.3. Whole Genomic Amplification kit
      • 4.3.3.1. Whole Genomic Amplification Kit Market, 2018 - 2030 (USD Million)
    • 4.3.4. Bisulfite Conversion Kit
      • 4.3.4.1. Bisulfite Conversion Kit Market, 2018 - 2030 (USD Million)
    • 4.3.5. RNA Sequencing Kit
      • 4.3.5.1. RNA Sequencing Kit Market, 2018 - 2030 (USD Million)
    • 4.3.6. Others
      • 4.3.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.5. Enzymes
    • 4.5.1. Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Epigenetics Diagnostics Market: Application Movement Analysis
  • 5.2. Oncology
    • 5.2.1. Oncology Market, 2018 - 2030 (USD Million)
    • 5.2.2. Solid Tumors
      • 5.2.2.1. Solid Tumors Market, 2018 - 2030 (USD Million)
    • 5.2.3. Others
      • 5.2.3.1. Others Market, 2018 - 2030 (USD Million)
  • 5.3. Non-oncology
    • 5.3.1. Non-oncology Market, 2018 - 2030 (USD Million)
    • 5.3.2. Inflammatory Diseases
      • 5.3.2.1. Inflammatory Diseases Market, 2018 - 2030 (USD Million)
    • 5.3.3. Metabolic Diseases
      • 5.3.3.1. Metabolic Diseases Market, 2018 - 2030 (USD Million)
    • 5.3.4. Infectious Diseases
      • 5.3.4.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
    • 5.3.5. Cardiovascular Diseases
      • 5.3.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
    • 5.3.6. Others
      • 5.3.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Epigenetics Diagnostics Market: Technology Movement Analysis
  • 6.2. DNA Methylation
    • 6.2.1. DNA Methylation Market, 2018 - 2030 (USD Million)
  • 6.3. Histone Methylation
    • 6.3.1. Histone Methylation Market, 2018 - 2030 (USD Million)
  • 6.4. Histone Acetylation
    • 6.4.1. Histone Acetylation Market, 2018 - 2030 (USD Million)
  • 6.5. Large noncoding RNA
    • 6.5.1. Large noncoding RNA Market, 2018 - 2030 (USD Million)
  • 6.6. MicroRNA modification
    • 6.6.1. MicroRNA modification Market, 2018 - 2030 (USD Million)
    • 6.7.1. Chromatin Structure Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Epigenetics Diagnostics Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. Germany Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. South Korea Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Roche Diagnostics
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Eisai Co. Ltd.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Novartis AG
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Element Biosciences, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Dovetail Genomics LLC.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Illumina, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. ValiRx Plc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Abcam plc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Type benchmarking
      • 8.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 U.S. Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 9 Canada Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 12 Europe Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 UK Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Germany Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 France Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 France Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24 France Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Italy Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Spain Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Denmark Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 34 Sweden Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 37 Norway Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 44 China Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 45 China Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 46 China Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Japan Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 50 India Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 India Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 India Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Australia Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 South Korea Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Thailand Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Latin America Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 63 Latin America Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Brazil Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Mexico Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Argentina Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 79 South Africa Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 85 UAE Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Epigenetics Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 PESTEL Analysis
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Epigenetics Diagnostics Market: Product Key Takeaways
  • Fig. 15 Global Epigenetics Diagnostics Market: Product Movement Analysis
  • Fig. 16 Global Epigenetics Diagnostics Market, For Reagents, 2018 - 2030 (USD Million)
  • Fig. 17 Global Epigenetics Diagnostics Market, For Kits, 2018 - 2030 (USD Million)
  • Fig. 18 Global Epigenetics Diagnostics Market, For Instruments, 2018 - 2030 (USD Million)
  • Fig. 19 Global Epigenetics Diagnostics Market, For Enzymes, 2018 - 2030 (USD Million)
  • Fig. 20 Global Epigenetics Diagnostics Market, For Services, 2018 - 2030 (USD Million)
  • Fig. 21 Global Epigenetics Diagnostics Market: Application Key Takeaways
  • Fig. 22 Global Epigenetics Diagnostics Market: Application Movement Analysis
  • Fig. 23 Global Epigenetics Diagnostics Market, For Oncology, 2018 - 2030 (USD Million)
  • Fig. 24 Global Epigenetics Diagnostics Market, For Non-oncology, 2018 - 2030 (USD Million)
  • Fig. 25 Global Epigenetics Diagnostics Market: Technology Key Takeaways
  • Fig. 26 Global Epigenetics Diagnostics Market: Technology Movement Analysis
  • Fig. 27 Global Epigenetics Diagnostics Market, For DNA Methylation, 2018 - 2030 (USD Million)
  • Fig. 28 Global Epigenetics Diagnostics Market, For Histone Methylation, 2018 - 2030 (USD Million)
  • Fig. 29 Global Epigenetics Diagnostics Market, For Histone Acetylation, 2018 - 2030 (USD Million)
  • Fig. 30 Global Epigenetics Diagnostics Market, For Large noncoding RNA, 2018 - 2030 (USD Million)
  • Fig. 31 Global Epigenetics Diagnostics Market, For MicroRNA modification, 2018 - 2030 (USD Million)
  • Fig. 32 Global Epigenetics Diagnostics Market, For Chromatin Structure, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 Regional Outlook, 2022 & 2030
  • Fig. 35 Global Epigenetics Diagnostics Market: Region Movement Analysis
  • Fig. 36 North America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East And Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)